{"id":50842,"date":"2025-07-14T10:00:50","date_gmt":"2025-07-14T08:00:50","guid":{"rendered":"https:\/\/www.maiwald.eu\/presseberichte\/royalty-pharma-and-revolution-medicines-sign-funding-agreements-worth-up-to-2-billion\/"},"modified":"2025-07-14T10:01:08","modified_gmt":"2025-07-14T08:01:08","slug":"royalty-pharma-and-revolution-medicines-sign-funding-agreements-worth-up-to-2-billion","status":"publish","type":"presseberichte","link":"https:\/\/www.maiwald.eu\/ko\/press-coverage\/royalty-pharma-and-revolution-medicines-sign-funding-agreements-worth-up-to-2-billion\/","title":{"rendered":"Royalty Pharma and Revolution Medicines Sign Funding Agreements Worth Up to $2 Billion"},"content":{"rendered":"\n<p>Royalty Pharma plc and Revolution Medicines, Inc. have announced a strategic funding collaboration of up to $2 billion to support the global development and commercialization of Revolution\u2019s RAS(ON) inhibitor portfolio, particularly the clinical advancement of lead candidate RMC-6236.<\/p>\n\n\n\n<p>The agreement includes a synthetic royalty deal and a senior secured credit facility. Revolution retains full rights to its programs, while Royalty Pharma secures a return based on future sales.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.royaltypharma.com\/news\/royalty-pharma-and-revolution-medicines-enter-into-funding-agreements-for-up-to-2-billion\/\" data-type=\"link\" data-id=\"https:\/\/www.royaltypharma.com\/news\/royalty-pharma-and-revolution-medicines-enter-into-funding-agreements-for-up-to-2-billion\/\" target=\"_blank\" rel=\"noopener\">You can read the full article here<\/a>.<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-50842","presseberichte","type-presseberichte","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.maiwald.eu\/ko\/wp-json\/wp\/v2\/presseberichte\/50842","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.maiwald.eu\/ko\/wp-json\/wp\/v2\/presseberichte"}],"about":[{"href":"https:\/\/www.maiwald.eu\/ko\/wp-json\/wp\/v2\/types\/presseberichte"}],"version-history":[{"count":1,"href":"https:\/\/www.maiwald.eu\/ko\/wp-json\/wp\/v2\/presseberichte\/50842\/revisions"}],"predecessor-version":[{"id":50845,"href":"https:\/\/www.maiwald.eu\/ko\/wp-json\/wp\/v2\/presseberichte\/50842\/revisions\/50845"}],"wp:attachment":[{"href":"https:\/\/www.maiwald.eu\/ko\/wp-json\/wp\/v2\/media?parent=50842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}